The Effect of Progressive Muscle Relaxation Exercises on Fatigue, Dyspnea, and Respiratory Function in Patients With Systemic Sclerosis
PMR-SCLERODERM
2 other identifiers
interventional
50
1 country
1
Brief Summary
This study aims to evaluate the effects of progressive muscle relaxation exercises on fatigue, dyspnea, and respiratory function in patients with systemic sclerosis. Participants will be assessed before and after the intervention.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Apr 2026
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 25, 2026
CompletedFirst Submitted
Initial submission to the registry
September 20, 2026
CompletedFirst Posted
Study publicly available on registry
September 25, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 10, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 25, 2026
September 25, 2026
September 1, 2026
7 months
September 20, 2026
September 20, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
Respiratory function measured by forced expiratory volume in 1 second (FEV1) and forced vital capacity (FVC)
Respiratory function will be assessed using spirometry, including forced expiratory volume in 1 second (FEV1) and forced vital capacity (FVC). Changes in FEV1 and FVC from baseline to post-intervention assessment will be evaluated between the intervention and control groups.
Baseline and 4 weeks after the intervention
Fatigue severity measured by the FACIT-Fatigue Scale
Fatigue will be assessed using the Functional Assessment of Chronic Illness Therapy-Fatigue (FACIT-Fatigue) Scale. Changes in fatigue scores from baseline to post-intervention assessment will be evaluated between the intervention and control groups.
Baseline and 4 weeks after the intervention
Dyspnea severity measured by the Dyspnea-12 (D-12) Scale
Dyspnea will be assessed using the Dyspnea-12 (D-12) Scale. Changes in dyspnea scores from baseline to post-intervention assessment will be evaluated between the intervention and control groups.
Baseline and 4 weeks after the intervention
Study Arms (2)
Progressive Muscle Relaxation Exercise Group
EXPERIMENTALParticipants randomly assigned to this group will receive progressive muscle relaxation exercises in addition to standard care.
Control Group
NO INTERVENTIONParticipants randomly assigned to this group will receive standard care without progressive muscle relaxation exercises.
Interventions
Participants in the intervention group will receive progressive muscle relaxation exercises according to the study protocol. The intervention will be administered in addition to standard care.
Eligibility Criteria
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Gaziantep University Vocational School of Health Services
Gaziantep, Şehitkamil, 27000, Turkey (Türkiye)
Related Publications (2)
Fairley JL, Hansen D, Proudman S, Baron M, Sahhar J, Ngian GS, Walker J, Host LV, Morrisroe K, Stevens W, Ross L, Nikpour M. The burden and determinants of fatigue in incident and prevalent systemic sclerosis. Clin Exp Rheumatol. 2024 Aug;42(8):1669-1674. doi: 10.55563/clinexprheumatol/6528od. Epub 2024 Aug 14.
PMID: 39152749RESULTYakut H, Ozalevli S, Birlik AM. Fatigue and its relationship with disease-related factors in patients with systemic sclerosis: A cross-sectional study. Turk J Med Sci. 2021 Apr 30;51(2):530-539. doi: 10.3906/sag-2005-314.
PMID: 32927933RESULT
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Adile Neşe, Associate Professor
University of Gaziantep
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Masking Details
- Participants and outcome assessors are blinded to group allocation. The researcher administering the intervention is aware of the group allocation.
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant Professor
Study Record Dates
First Submitted
September 20, 2026
First Posted
September 25, 2026
Study Start
April 25, 2026
Primary Completion (Estimated)
November 10, 2026
Study Completion (Estimated)
December 25, 2026
Last Updated
September 25, 2026
Record last verified: 2026-09
Data Sharing
- IPD Sharing
- Will not share
Individual participant data will not be shared with other researchers. Data will be used only for the purposes of this study and will be handled in accordance with applicable ethical and data protection requirements.